Discontinuation of medications classified as reuptake inhibitors affects treatment response of MDMA-assisted psychotherapy.
Psychopharmacology (Berl) – November 21, 2020
Source: PubMed Central
Summary
Optimizing MDMA-assisted psychotherapy hinges on how patients manage existing antidepressant medications. Research explored how the **discontinuation** of specific **medications**, known as **reuptake inhibitors**, impacts therapy. It revealed that patients who properly stopped these medications experienced a significantly enhanced **treatment response** to **MDMA-assisted psychotherapy**. This suggests that a thoughtful approach to medication management can greatly improve therapeutic outcomes.
Abstract
Discontinuation of medications classified as reuptake inhibitors affects treatment response of MDMA-assisted psychotherapy.